Silence Therapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 224K (forecast USD 4.637M), actual EPS USD -0.5791 (forecast USD -0.1785)

Brief Summary

Silence Therapeutics reported a Q2 2025 revenue of $224,000, significantly missing the expected $4.64 million, and an EPS of -$0.5791, which also missed the expected -$0.1785.

Impact of The News

The financial performance of Silence Therapeutics in Q2 2025 fell significantly short of market expectations.